Premarket Biotech Digest: Understanding Multiple Sclerosis, Gilead's Hep C Sales, AstraZeneca Halts Trial
13 October 2015 - 12:51AM
Seeking Alpha
http://seekingalpha.com/article/3565686-premarket-biotech-digest-understanding-multiple-sclerosis-gileads-hep-c-sales-astrazeneca-halts-trial?source=partner_advfn&utm_source=advfn&utm_medium=cpc&utm_campaign=investorshub
Bristol Myers Squibb (NYSE:BMY)
Historical Stock Chart
From Apr 2024 to May 2024
Bristol Myers Squibb (NYSE:BMY)
Historical Stock Chart
From May 2023 to May 2024